March 13, 2014
ARLINGTON, Va. — HDMA President and CEO John M. Gray released the following statement regarding U.S. Attorney General Eric Holder's weekly address concerning the nation's prescription drug abuse epidemic.
"HDMA applauds United States Attorney General Eric Holder for addressing the prescription drug abuse epidemic our country faces. AG Holder's call for a multi-faceted approach to combat this public health challenge is the right one. The recent rise in heroin use — as well as emerging concerns about the inability of patients to access their legitimately prescribed medications — reaffirms the need to create a comprehensive and collaborative strategy that provides equal weight to enforcement, public health and treatment efforts.
"Recognizing that there is no one-size-fits-all solution, pharmaceutical distributors, along with their supply chain partners, are committed to a more coordinated and transparent approach to address the prescription drug abuse problem. The complexity of this public health challenge will require the entire healthcare supply chain to work together in close partnership with state and federal entities to effectively stem the tide of prescription drug abuse and minimize the potential for unintended consequences.
"HDMA looks forward to working with all stakeholders to develop and implement solutions that begin to bring the prescription drug abuse epidemic under control, ensure patient safety and allow for continued access to medicines for legitimate patients."
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.